SEC Comment Letter for VivoSim Labs, INC. (VIVS) (CIK 0001497253) (VIVS) — Feb 16, 2018
VivoSim Labs, INC. (VIVS) (CIK 0001497253)
Date: Feb. 16, 2018 · CIK: 0001497253 · Accession: 0000000000-18-005472
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-222929
Letter
February 16, 2018 Taylor Crouch Chief Executive Officer Organovo Holdings, Inc. 6275 Nancy Ridge Drive, Suite 110 San Diego, CA 92121 Re:Organovo Holdings, Inc. Registration Statement on Form S-3 Filed February 8, 2018 File No. 333-222929 Dear Mr. Crouch: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Jeffrey C. Thacker, Esq.
Show Raw Text
February 16, 2018
Taylor Crouch
Chief Executive Officer
Organovo Holdings, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Re:Organovo Holdings, Inc.
Registration Statement on Form S-3
Filed February 8, 2018
File No. 333-222929
Dear Mr. Crouch:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Jeffrey C. Thacker, Esq.